Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for TOC Method Development for Cleaning Validation – V 2.0

Posted on By

Analytical Method Development: SOP for TOC Method Development for Cleaning Validation – V 2.0

Standard Operating Procedure for TOC Method Development in Cleaning Validation


Department Analytical Method Development
SOP No. SOP/AMD/176/2025
Supersedes SOP/AMD/176/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

To establish a standard procedure for developing and validating a Total Organic Carbon (TOC) method for use in cleaning validation programs, ensuring trace-level detection of organic residues on

manufacturing equipment surfaces following product changeovers or cleaning activities.

2. Scope

This SOP applies to the Analytical Method Development (AMD) and Quality Control departments for the development, validation, and application of TOC analysis in evaluating the effectiveness of equipment cleaning in pharmaceutical manufacturing facilities.

3. Responsibilities

  • Analytical Scientist: Develops TOC method, defines validation protocol, interprets results.
  • Instrument Analyst: Operates TOC analyzer, performs calibration and sample analysis.
  • QA Officer: Reviews and approves TOC data and validation reports.
  • Head – AMD: Ensures validation protocols meet regulatory and GMP requirements.
See also  Analytical Method Development: SOP for Calibration of HPLC Systems - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the TOC method meets sensitivity and specificity standards necessary for compliance with cleaning validation guidelines.

5. Procedure

5.1 Instrument and System Calibration

  1. Use a TOC analyzer capable of detecting down to 0.05 ppm C.
  2. Perform system suitability using potassium hydrogen phthalate (KHP) and sodium benzoate standards.
  3. Conduct calibration with a minimum of 5 concentration levels (e.g., 0.1 to 2.0 ppm C).
  4. Validate calibration curve (R² ≥ 0.995) and document in Annexure-1: TOC Calibration Log.

5.2 Sample Collection

  1. Collect swab or rinse samples from cleaned equipment surfaces using validated sampling procedures.
  2. Use low TOC-grade water and pre-cleaned containers for dilution and collection.
  3. Label and store samples at 2–8°C if analysis is delayed beyond 4 hours.

5.3 Method Parameters

  1. Sample Introduction: Non-purgeable organic carbon (NPOC) mode preferred.
  2. Oxidation Technique: High-temperature combustion (680–720°C) or UV/persulfate oxidation.
  3. Detection Method: Non-dispersive infrared (NDIR) or conductivity-based detection.
  4. Injection Volume: Typically 50–1000 µL depending on instrument sensitivity.
See also  Analytical Method Development: SOP for Conducting Filter Compatibility Studies - V 2.0

5.4 Method Validation

  1. Validate per ICH Q2(R2) and cleaning validation requirements:
    • Specificity: Ensure water, container, and swab do not interfere.
    • Linearity: 0.05 to 2.0 ppm C (R² ≥ 0.995).
    • LOD/LOQ: Based on S/N ratio (3:1 and 10:1).
    • Accuracy: 85%–115% recovery using spiked samples.
    • Precision: RSD ≤ 5% for replicate injections.
    • Robustness: Evaluate effect of different swab types and rinsing media.
  2. Document in Annexure-2: Validation Summary.

5.5 Application in Cleaning Validation

  1. Define acceptable TOC limit based on:
    • 10 ppm general limit or
    • Calculation from 1/1000th of minimum therapeutic dose or < 0.1% carryover
  2. Perform TOC analysis post-cleaning on worst-case equipment trains.
  3. Compare results to established acceptance criteria.
  4. Document all results in Annexure-3: Cleaning Validation TOC Report.

6. Abbreviations

  • TOC: Total Organic Carbon
  • NPOC: Non-Purgeable Organic Carbon
  • NDIR: Non-Dispersive Infrared
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • SOP: Standard Operating Procedure

7. Documents

  1. TOC Calibration Log – Annexure-1
  2. Validation Summary – Annexure-2
  3. Cleaning Validation TOC Report – Annexure-3
See also  Analytical Method Development: Development of Test Procedures for Formulations - V 2.0

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • FDA Guidance for Cleaning Validation
  • USP <643> – Total Organic Carbon
  • WHO Technical Report Series on Cleaning Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: TOC Calibration Log

Standard (ppm C) Instrument Reading Deviation (%) Analyst
0.5 0.48 –4.0 Rajesh Kumar
1.0 0.98 –2.0 Rajesh Kumar

Annexure-2: Validation Summary

Parameter Result Acceptance Status
Linearity (R²) 0.9986 ≥ 0.995 Pass
Recovery 92%–108% 85%–115% Pass
Precision RSD = 3.1% ≤ 5% Pass

Annexure-3: Cleaning Validation TOC Report

Sample ID Surface Area (cm²) TOC Result (ppm) Limit (ppm) Status
Rinse-API-MX01 1200 0.6 1.0 Complies

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded robustness section and updated detection criteria Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Operating Vacuum Transfer Systems – V 2.0
Next Post: Creams: SOP for Product Quality Reviews (PQRs) for Creams – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version